Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis Venture Fund
Biotech
With $105M and Big Pharma backing, Mediar takes aim at fibrosis
With a who’s who of Big Pharma on board and over $100 million, Mediar is gearing up to see whether its fibrosis therapies will deliver in the clinic.
James Waldron
Mar 15, 2023 8:21am
Biotech Oculis sees SPAC potential, signs deal with EBAC
Oct 17, 2022 3:10pm
Novartis-backed ImmPACT Bio gets $111M, ex-Pfizer exec for CEO
Jan 20, 2022 5:00am
Novartis tries to avoid 'me-too' meds in M&A hunt
Jan 19, 2022 4:10pm
Pfizer, Novartis back $119M Anaveon series B for phase 2 trials
Dec 16, 2021 12:57pm
Novartis-backed Exo says 'XO' to investors for $78M series B
Oct 5, 2021 6:00am
